A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty

Journal of Arthroplasty

Volumn 16, Issue 3, 2001, Pages 293-300

  Brookenthal, K R ^a   Freedman, K B ^a   Lotke, P A ^a   Fitzgerald, R H ^a   Lonner, J H ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Meta analysis; Thromboembolic disease; Total knee arthroplasty

Indexed keywords

ACETYLSALICYLIC ACID; DEXTRAN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; META ANALYSIS; MORTALITY; PHLEBOGRAPHY; PROPHYLAXIS; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

EID: 0035048790     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1054/arth.2001.21499     Document Type: Article

References (67)

1. Comparison of warfarin use in total knee replacement vs total hip replacement
2. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty
3. Incidence of fatal pulmonary embolism after 1, 390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases
4. Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis
5. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective total knee arthroplasty
6. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty
7. Pulmonary embolism after hip or knee replacement: Post-operative changes on pulmonary scintigrams in asymptomatic patients
8. Anti-thrombin III prophylaxis of venous thromboembolic disease after total hip or total knee arthroplasty
9. Prevention of venous thrombosis after total knee arthroplasty
10. Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin
11. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement
12. Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery
13. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty
14. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep venous thrombosis in elective hip and knee replacement?
15. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-blind, dose-ranging study
16. Prevention of deep vein thrombosis after total knee arthroplasty
17. Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement
18. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation
19. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation
20. Intermittent pneumatic compression versus coumadin: Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty
21. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation
22. The incidence of deep vein thrombosis after cementless and cemented knee replacement
23. A randomized trial of enoxaparin for the prevention of deep vein thrombosis after major knee surgery
24. Prevention of venous thromboembolism after knee arthroplasty
25. Pulmonary embolism in total hip and knee arthroplasty
26. Color duplex Doppler ultrasound scanning for detection of deep venous thrombosis in total knee and hip arthroplasty patients: Incidence, location, and diagnostic accuracy compared with ascending venography
27. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism
28. Low-dose warfarin prophylaxis to prevent symptomatic pulmonary embolism after total knee arthroplasty
29. Deep-vein thrombosis and continuous passive motion after total knee arthroplasty
30. Mechanical measures in the prophylaxis of postoperative thromboembolism in total knee arthroplasty
31. Death rate from pulmonary embolism
32. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression
33. Venous thromboembolism associated with hip and knee arthroplasty
34. Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty
35. Establishing a universal protocol for deep vein thrombosis following orthopedic surgery: Total knee arthroplasty
36. Enoxaparin: A low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery
37. Deep vein thrombosis after elective knee surgery: An incidence study in 312 patients
38. Enoxaparin: A low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery
39. Deep-vein thrombosis following total knee replacement: An analysis of six hundred and thirty-eight arthroplasties
40. Antithrombin III/low-dose heparin in the prevention of deep-vein thrombosis after total knee arthroplasty
41. Asymptomatic deep venous thrombosis in the calf: Accuracy and limitations of ultrasonography as a screening test after total knee arthroplasty
42. Incidence of pulmonary embolism after total knee arthroplasty with low-dose coumadin prophylaxis
43. Comparative risk of early postoperative pulmonary embolism after cemented total knee versus total hip arthroplasty with low-dose warfarin prophylaxis
44. Symptomatic venous thromboembolism after total knee replacement
45. Prophylaxis against deep venous thrombosis after total knee arthroplasty
46. Thromboembolic prophylaxis in total knee replacement: Evaluation of the A-V Impulse system
47. Warfarin-induced necrosis of the skin
48. Warfarin-induced skin necrosis
49. Late-onset warfarin-induced skin necrosis: Case report
50. Complications associated with warfarin prophylaxis in total knee arthroplasty
51. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia
52. Acute adrenal insufficiency secondary to heparin-induced thrombocytopenia-thrombosis syndrome
53. Heparin induced thrombocytopenia
54. The clinical management of heparin-induced thrombocytopenia
55. New treatment options for heparin-induced thrombocytopenia
56. Complications of heparin therapy after total joint arthroplasty
57. Necrotizing skin lesions induced by low-molecular-weight heparin after total knee arthroplasty
58. Hematologic complications of heparin-induced thrombocytopenia
59. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy
60. Clinical presentation of heparin-induced thrombocytopenia
61. Heparin-induced thrombocytopenia: A ten-year retrospective
62. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty: A meta-analysis of randomized trials
63. The role of mechanical and other adjuncts
64. Thromboembolic prophylaxis in total knee replacement: Evaluation of the A-V Impulse system
65. Preventing DVT following total knee replacement: A review of recent clinical trials
66. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty